1Seidenfeld J, Samson DJ, Hasselblad V, et al. Single-therapy androgen suppression in men with advanced prostate cancer, asystematic review and meta-analysis[JJ . Ann Intern Med, 2000, 132: 566-577.
3Seidenfeld J, Sawn DJ, Hasselblad V, et al. Single-therapy androgen suppression in men with advanced prostate cancer, asystematic review and meta-analysis[J]. Ann Intern Med, 2000, 132 : 566-577.
4McLeod D, Zinner N, Tomera K, et al. Aphase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer [J]. Urology, 2001,58 : 756-761.
5Trachtenberg J, Gittleman M, Steidle C, et al. A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer [J]. J Urol, 2002, 167 : 1670-1674
6Waymont B, Lynch TH, Dunn JA, et al. Phase Ⅲ randomized study of zoladex versus stilboestrol in the treatment of advanced prostate cancer[J]. Br J Urol, 1992, 69:614-620.
7Schroder FH, Whelan P, de Reijke TM, et al . Metastatic prostate cancer treated by f lutamide versus cyproterone acetate . Final a nalysis of the "European organization for research and treatment of cancer"(EORTC) protocol 30892 [J] . Eur Urol, 2004, 45:4572464.
8Chodak G, Sharifi R, Kasimis B, et al. Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma [J] . Urology, 1995, 46: 849-855.
9Thompson IM, Lucia MS, Redman MW, et al. Finasteride decreases the risk of prostatic intraepithelial neoplasia [J] . J Urol, 2007, 178 (1) : 107-109.
10Kazuhiko Ogawa, Katsumasa Nakamura, Hiroshi Onishi, Radical External Beam Radiotherapy for Prostate Cancer in Japan: Results of the 1999-2001 Patterns of Care Process Survey[J] .Japanese Journal of Clinical Oncology, 2006, 36( 1 ) : 40-4.
二级参考文献39
1Seidenfeld J,Samson DJ,Hasselblad V,et al.Single-therapy androgen suppression in men with advanced prostate cancer:a systematic review and meta-analysis[J].Ann Intern Med,2000,132:566-577.
2Byar DP.The Veteran's Administration Cooperative Urological Group's studies of carcinoma of the prostate[J].Cancer,1973,32:1126-1130.
3Robinson MR,Smith PH,Richards B,et al.The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase Ⅲ clinical trial (protocol 30805) compaing orchidectomy,orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate[J].Eur Urol,1995,28:273-283.
4Leuprolide versus diethylstilbestrol for metastatic prostate cancer.The Leuprolide Study Group[J].N Engl J Med,1984,311:1281-1286.
5Leuprolide versus diethylstilbestrol for metastatic prostate cancer.The Leuprolide Study Group[J].N Engl J Med,1984,311(20):1281-1286.
6Kaisary AV,Tyrrell CJ,Peeling WB,et al.Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma[J].Br J Urol,1991,67:502-508.
7Vogelzang NJ,Chodak GW,Soloway MS,et al.Goserelin versus orchiectomy in the treatment of advanced prostate cancer:final results of a randomized trial[J].Zoladex Prostate Study Group.Urology,1995,46:220-226.
8McLeod D,Zinner N,Tomera K,et al.A phase 3,multicenter,open-label,randomized study of abarelix versus leuprolide acetate in men with prostate cancer[J].Urology,2001,58:756-761.
9Trachtenberg J,Gittleman M,Steidle C,et al.A phase 3,multicenter,open label,randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer[J].J Urol,2002,167:1670-1674.
10Boccon-Gibod L,Fournier G,Bottet P,et al.Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma[J].Eur Urol,1997,32:391-395.
4WIRTH M, TYRRELL C, DELAERE K, et al. Bicalutamide ( "Casodex" ) 150 tug in addition to standard care in patients with nonmetastatic prostate cancer : updated results from a randomized double-blind phase Ⅲ study (median follow-up 5. l y) in the early prostate cancer programme[ J ]. Prostate Cancer Prostatic Dis, 2005,8 ( 2 ) : 194-200.
5LABRIE F, BELANGER A, DUPONT A, et al. Science behind total androgen blockade from gene to combination the rapy [ J ]. Clin Invest Med, 1993,16 ( 7 ) :475 -492.
6Scher H I, Liebertz C, Kelly W K, et al.Bicalu tam id e for advanced prostate cancer the nature versus treated history of disease[J].J Clin On col, 1997, 15(8): 2928-2938.
7IAKAZAH, HINOq'SUS.Combined androgen blockade with bicalu-tamide for advanced prostate cancer: long-term follow-up of a phase3, double- blind, randomized study for survival[J].Cancer, 2009, 115(15): 1336.
8Utsunomiya D, Shiraishi S, Imuta M, et al.Added value of SPECT/ CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT[J].Radiology, 2006, 238(1): 264-271.
9Dahut W L, Gulley J L, Arlen P M, et al.Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer[J]. Journal of Clinical Oncology, 2004, 22(13): 2226-2228.
